Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Tampa, Florida 33612


Purpose:

The purpose of this study is to evaluate Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) with fatigued chronic myelogenous leukemia (CML) patients on tyrosine kinase inhibitors (TKIs) for feasibility, acceptability and potential efficacy relative to usual care only in a small-scale randomized controlled trial.


Criteria:

Inclusion Criteria: - able to speak/read English - diagnosed with chronic phase CML - not have been treated for other cancer (except non-melanoma skin cancer) in the past 5 years - be under the care of a Moffitt Cancer Center (MCC) physician - be on a stable dose of the same oral TKI for >= 3 months - new onset or worsening of fatigue since starting TKI - report moderate-severe fatigue in past week (FSI average rating >= 4 of 0-10) - have no clinical history of disease (e.g., multiple sclerosis, fibromyalgia) that could account for their fatigue presentation Exclusion Criteria: - scheduled to discontinue their TKI under medical supervision within the next 3 months


NCT ID:

NCT02592447


Primary Contact:

Principal Investigator
Heather Jim, Ph.D.
H. Lee Moffitt Cancer Center and Research Institute


Backup Contact:

N/A


Location Contact:

Tampa, Florida 33612
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.